Wolfe Research upgraded Inspire Medical (INSP) to Outperform from Peer Perform with an $180 price target The firm says the company’s “surprise” reimbursement increase adds conviction in the bull case for the shares. Wolfe’s price target represents 5-times Inspire’s estimated 2026 revenue.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on INSP: